Investigational Drugs with Clinical Trials for: Hyperlipoproteinemia Type II
✉ Email this page to a colleague
Drugname | Indication |
---|---|
Lapaquistat | Hyperlipoproteinemia Type II |
MGL-3196 | Hyperlipoproteinemia Type II |
Obicetrapib | Hyperlipoproteinemia Type II |
>Drugname | >Indication |